rs61735812

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_006031.6(PCNT):​c.6739C>T​(p.His2247Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0106 in 1,563,558 control chromosomes in the GnomAD database, including 127 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. H2247H) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.015 ( 23 hom., cov: 32)
Exomes 𝑓: 0.010 ( 104 hom. )

Consequence

PCNT
NM_006031.6 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.182

Publications

12 publications found
Variant links:
Genes affected
PCNT (HGNC:16068): (pericentrin) The protein encoded by this gene binds to calmodulin and is expressed in the centrosome. It is an integral component of the pericentriolar material (PCM). The protein contains a series of coiled-coil domains and a highly conserved PCM targeting motif called the PACT domain near its C-terminus. The protein interacts with the microtubule nucleation component gamma-tubulin and is likely important to normal functioning of the centrosomes, cytoskeleton, and cell-cycle progression. Mutations in this gene cause Seckel syndrome-4 and microcephalic osteodysplastic primordial dwarfism type II. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]
PCNT Gene-Disease associations (from GenCC):
  • microcephalic osteodysplastic primordial dwarfism type II
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • Moyamoya disease
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0025939345).
BP6
Variant 21-46416657-C-T is Benign according to our data. Variant chr21-46416657-C-T is described in ClinVar as Benign. ClinVar VariationId is 138627.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0151 (2299/152288) while in subpopulation AFR AF = 0.0253 (1050/41568). AF 95% confidence interval is 0.024. There are 23 homozygotes in GnomAd4. There are 1149 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 23 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PCNTNM_006031.6 linkc.6739C>T p.His2247Tyr missense_variant Exon 30 of 47 ENST00000359568.10 NP_006022.3 O95613-1
PCNTNM_001315529.2 linkc.6385C>T p.His2129Tyr missense_variant Exon 30 of 47 NP_001302458.1 O95613-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PCNTENST00000359568.10 linkc.6739C>T p.His2247Tyr missense_variant Exon 30 of 47 1 NM_006031.6 ENSP00000352572.5 O95613-1

Frequencies

GnomAD3 genomes
AF:
0.0151
AC:
2293
AN:
152170
Hom.:
23
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0252
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0124
Gnomad ASJ
AF:
0.0147
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00559
Gnomad FIN
AF:
0.0212
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.0104
Gnomad OTH
AF:
0.0210
GnomAD2 exomes
AF:
0.0118
AC:
2409
AN:
204038
AF XY:
0.0118
show subpopulations
Gnomad AFR exome
AF:
0.0266
Gnomad AMR exome
AF:
0.0109
Gnomad ASJ exome
AF:
0.0142
Gnomad EAS exome
AF:
0.000231
Gnomad FIN exome
AF:
0.0217
Gnomad NFE exome
AF:
0.0109
Gnomad OTH exome
AF:
0.0120
GnomAD4 exome
AF:
0.0101
AC:
14198
AN:
1411270
Hom.:
104
Cov.:
34
AF XY:
0.0100
AC XY:
6991
AN XY:
696664
show subpopulations
African (AFR)
AF:
0.0288
AC:
922
AN:
32054
American (AMR)
AF:
0.00984
AC:
383
AN:
38920
Ashkenazi Jewish (ASJ)
AF:
0.0124
AC:
275
AN:
22186
East Asian (EAS)
AF:
0.000102
AC:
4
AN:
39378
South Asian (SAS)
AF:
0.00557
AC:
427
AN:
76648
European-Finnish (FIN)
AF:
0.0199
AC:
992
AN:
49968
Middle Eastern (MID)
AF:
0.0154
AC:
84
AN:
5466
European-Non Finnish (NFE)
AF:
0.00960
AC:
10448
AN:
1088534
Other (OTH)
AF:
0.0114
AC:
663
AN:
58116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
821
1641
2462
3282
4103
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
384
768
1152
1536
1920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0151
AC:
2299
AN:
152288
Hom.:
23
Cov.:
32
AF XY:
0.0154
AC XY:
1149
AN XY:
74464
show subpopulations
African (AFR)
AF:
0.0253
AC:
1050
AN:
41568
American (AMR)
AF:
0.0123
AC:
189
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0147
AC:
51
AN:
3464
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5164
South Asian (SAS)
AF:
0.00559
AC:
27
AN:
4830
European-Finnish (FIN)
AF:
0.0212
AC:
225
AN:
10628
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.0104
AC:
708
AN:
68008
Other (OTH)
AF:
0.0208
AC:
44
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
122
244
367
489
611
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0117
Hom.:
35
Bravo
AF:
0.0152
TwinsUK
AF:
0.00863
AC:
32
ALSPAC
AF:
0.0101
AC:
39
ESP6500AA
AF:
0.0203
AC:
89
ESP6500EA
AF:
0.0110
AC:
94
ExAC
AF:
0.0114
AC:
1374
Asia WGS
AF:
0.00491
AC:
17
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 06, 2015
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 09, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Microcephalic osteodysplastic primordial dwarfism type II Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Oct 29, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.083
BayesDel_addAF
Benign
-0.73
T
BayesDel_noAF
Benign
-0.80
CADD
Benign
1.2
DANN
Benign
0.65
DEOGEN2
Benign
0.033
T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.010
N
LIST_S2
Benign
0.71
T
MetaRNN
Benign
0.0026
T
MetaSVM
Benign
-0.96
T
MutationAssessor
Benign
1.1
L
PhyloP100
0.18
PrimateAI
Benign
0.27
T
PROVEAN
Benign
0.64
N
REVEL
Benign
0.038
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Polyphen
0.78
P
Vest4
0.062
MPC
0.22
ClinPred
0.0022
T
GERP RS
-1.6
Varity_R
0.037
gMVP
0.11
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61735812; hg19: chr21-47836571; API